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Necrobiotic Xanthogranuloma in Female with Monoclonal Gammopathy of Undetermined Significance
Carl Barrick, DO and Tanya Ermolovich, DO
Lehigh Valley Health Network, Allentown, PA

Case Presentation

Discussion
Necrobiotic xanthogranuloma (NXG) is a rare multisystem disease with cutaneous findings that were first described by
Kossard and Winkelmann in 1980. NXG is characterized by red-brown, violaceous, or yellowish cutaneous papules and
nodules that progress to form infiltrated plaques. The cutaneous lesions are most commonly located in the periorbital
region in more than 80% of patients. The trunk and proximal extremities can also present with large plaques that may
present within scars. These skin lesions can grow to 25cm in diameter. The plaques may ulcerate centrally and heal
with atrophic scars.

Patient: 62 year-old Caucasian female.
History of Present Illness: Patient presents with yellow to pink
dermal nodule on midline superior pubis, overlying previous cesarean-section
scar. A biopsy was performed and the histopathology listed a vast differential
diagnosis including ruptured cyst. A few months later a similar lesion developed
on the left abdomen and then left anterior neck. With further questioning a
similar lesion was removed on her left anterior neck by a plastic surgeon a few
years ago.
Medical/Surgical History: Monoclonal gammopathy of
undetermined significance, hip replacement, cholecystectomy, breast
lumpectomy, cesarean-section, hysterectomy, bladder sling, liposuction, back,
shoulder surgery

Fig. 1
Figure 1: Midline superior pubis. Yellow plaque with red-brown rim over-lying
pre-existing Cesarean section scar.

Family History: Hypertension, lung cancer, non-melanoma skin cancer
Medications: Desoximetasone 0.25% cream, mometasone inhaler,
levothyroxine sodium, vitamin B complex, krill oil, green tea, vitamin D-3,
calcium, curcumin, potassium, vitamin C

Histopathology reveals areas of disrupted and degenerated collagen (necrobiosis) surrounded by palisading foamy
macrophages. The alternating necrobiosis and granulomas give a layered appearance to the overall architecture of the
specimen. Atypical and Touton giant cells are found throughout the affected tissue. Cholesterol clefts, lipid deposits,
lymphoid follicles, and plasma cells are often seen. The histopathological differential includes necrobiosis lipoidica,
which has less atypical giant cells, lymphoid nodules, and cholesterol clefts.

Current Treatments: Intralesional triamcinolone 0.5cc of 20mg/cc,
desoximetasone 0.25% cream, ongoing hematologic monitoring under direction
of oncology
Physical Examination: Yellow-to-pink firm 1.3cm x 0.7cm dermal/
subcutaneous nodule on left anterior neck overlying a thin scar. Additionally,
patient has a 3cm x 1.4cm yellow plaque with red-brown rim on midline
superior pubis and left abdomen.
Laboratory Data: WBC 2.1thou/cmm (4.0-10.0), absolute neutrophils
1.0thou/cmm (1.6-7.0) absolute monocytes 0.1thou/cmm (0.2-1.3), monocytes
4% (5-13%), albumin 3.1g/dL (3.5-4.8), ESR 110 (0-30), Total IgG 3088mg/
dL (680-1445), IgA 82mg/dL (83-407), SPEP-elevated gamma region 2.5g/d/L
(0.7-1.7), album serum 3.9g/dL (4.1-5.1), ESR 94mm/hr (0-30). Lupus
thrombotic risk acquired panel WNL. CMP, CBC, cholesterol panel, C3, C4, CRP,
RF, UA, cardiolipin Ab, dsDNA, ANA, ANCA, B-2-glycoprotein, CCP, SM/RNP, Sm,
Scl-70, SSA, SSB, ACE1, centromere, HLA-B27 were all negative or WNL

Extracutaneous involvement most commonly affects the eyes, but can involve the lungs, heart, larynx, and kidneys.
Eye involvement can present as burning, itching, or eye pain. Conjunctivitis, uveitis, iritis, scleritis, keratitis, ectropion,
and proptosis have been reported with NXG. In approximately 80% of NXG cases, a plasma cell dyscrasia is
reported including monoclonal gammopathy of undetermined significance (MGUS), smoldering multiple myeloma,
and multiple myeloma. IgG monoclonal gammopathy is the most common associated paraproteinemia. Other
hematologic malignancies including non-Hodgkin lymphoma, chronic lymphocytic leukemia, Hodgkin lymphoma, and
lymphoplasmacytic lymphoma have been reported in association with NXG.

Fig. 2
Figure 2: H&E (4x). Punch biopsy. Left anterior neck: Large nodule with dense
epithelioid cells and broad ribbon-like, intersecting zones of degenerating
collagen.

The treatment of NXG is directed at the underlying paraproteinemia or malignancy. Treatment of the underlying disease
can lead to resolution of cutaneous manifestations. If the lesions remain persistent there are several cutaneous directed
therapies including, systemic corticosteroids, interferon alpha, alkylating agents, and plasmapheresis. Patients with
NXG have an increased risk of hematologic malignancies and therefore should undergo appropriate screening with
hematology oncology.

References:
1.	Kossard S, Winkelmann RK. Necrobiotic xanthogranuloma with paraproteinemia. J Am Acad Dermatol. 1980; 3:257-70.
2.	Higgins L et al. Clinical features and treatment outcomes of patients with necrobiotic xanthogranuloma associated with monoclonal
gammopathies. Clin Lymphoma Myeloma Leuk. 2016; 16:447-52.
3.	Szalat R et al. Physiopathology of necrobiotic xanthogranuloma with monoclonal gammopathy. J. Intern Med. 2014; 276: 269–84.

Studies: CXR, EKG, echocardiogram, mammogram all WNL
Biopsy: Advanced Dermatology Associates, LTD (AD16-12308,
10/19/2016) Left anterior neck: “Effacing the dermis is a large nodule
characterized by dense collections of epithelioid cells, numerous multinucleate
giant cells (many of which are Touton type) and broad ribbon-like, intersecting
zones of degenerating collagen that sometimes contain prominent collections
of cholesterol clefts.”
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Fig. 3
Figure 3: H&E (20x). Punch biopsy specimen from left neck show-ing multiple
Touton giant cells and areas of degenerated collagen.

